The tuberculosis prevalence in India has shown a significant decline over the past decade. The value stood at 211 cases per hundred thousand persons in 2013 and decreased steadily to 86 cases in 2023. Year-on-year reductions fluctuated, with the highest decline of 11.34% observed between 2022 and 2023. Over the last two years, the decline averaged around 11.18%. The Compound Annual Growth Rate (CAGR) over the five years leading to 2023 was -9.92%, indicating a consistent annual decrease in TB prevalence. Looking forward to the 2024-2028 period, the forecasted CAGR is -18.04%, suggesting a steep decline, with prevalence estimated to drop to 27 cases per hundred thousand persons by 2028, equivalent to a 63.01% reduction.
Future trends to watch for:
• Continued advancements in early detection and intervention.
• Increase in public health campaigns and improved access to healthcare facilities.
• Impact of new vaccines and treatment protocols.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...